ARCHIVE ISSUES – JUNE 2020

JUNE Issue

Using tears for precision diagnostics and the development of a potential new therapy for age- related macular degeneration

The dal-GenE trial: A case study of precision medicine in the cardiovascular setting

Using Zebrafish to Advance Disease Research

Pioneering precision medicine in rheumatoid arthritis

Companion Diagnostics, Precision Medicine and Immuno-Oncology Therapies

Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities

COVID‑19 and pharmacogenomics: an association that warrants comprehensive assessment

Lessons from oncology drive precision medicine across clinical specialties

A New Playbook for Cure-Seeking Nonprofits

Personalization and standardization: Can we have it all?

Personalized Medicine in the Aftermath of COVID-19

Focused On Precision Data

Diagnosing and Tracking COVID-19 Infections Leveraging Next-Gen Sequencing

Quick Take on Pharmacogenomics

The Burden of Proof – What Laboratories Need to Know About Evidence Development Before Launching a New Test

Expanding areas of impact for clinical diagnostics and precision medicine

How Cancer Patients Should Respond to the COVID-19 Pandemic

Quick Takes

The Journey to a COVID-19 Diagnostic Test

Clinical and real-world insights

The Licensing Conundrum

Why Standardizing the Use of Precision Medicine Should Be a Top Priority for Cancer Centers

Expert Feedback on Pain Points and Evolution in The Precision Medicine Landscape

BACK TO ARCHIVE